Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

Approval Number

国药准字H20223168

Company江苏长泰药业股份有限公司

Registration Date

March 22, 2022

Drug Information

Generic Name

盐酸左沙丁胺醇雾化吸入溶液

Dosage Form

吸入制剂

Strength

3ml：1.25mg（按C13H21NO3计）

Drug Type

化学药品

Registration Date

March 22, 2022

Company Information

Applicant Company

Company Name江苏长泰药业股份有限公司

Company Address

泰州市中国医药城南坝塘路1号

Manufacturing Company

Company Name江苏长泰药业股份有限公司

Company Address

泰州市中国医药城南坝塘路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy